NEKTAR THERAPEUTICS — Director's Dealing 2025

Oct 2, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2025-09-30

Reporting Person: CHESS ROBERT (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-09-30	Stock Option	$56.90	A	8000	Acquired	2033-09-29	Common Stock (8000)	Direct

Footnotes

F1: This stock option vests in substantially equal monthly installments over the one-year period beginning on September 30, 2025.